Company Filing History:
Years Active: 2025
Title: The Innovations of Stuart Kupfer
Introduction
Stuart Kupfer is an accomplished inventor based in Highland Park, IL (US). He has made significant contributions to the field of cardiology through his innovative patent. His work focuses on methods for treating hypertrophic cardiomyopathy, a condition that can lead to serious heart complications.
Latest Patents
Stuart Kupfer holds a patent for "Methods for treating hypertrophic cardiomyopathy." This patent describes treatment methods that include the administration of a cardiac myosin inhibitor, specifically CK-3773274, also known as CK-274 or aficamten. The methods involve titrating the daily dose based on various components of an echocardiogram, allowing for personalized treatment plans. The daily dose may be adjusted based on the echocardiogram results, ensuring optimal patient care.
Career Highlights
Stuart is associated with Cytokinetics, Inc., a company dedicated to developing innovative treatments for serious diseases. His work at Cytokinetics has positioned him as a key player in the advancement of therapies for heart conditions. With a focus on research and development, he continues to contribute to the medical field.
Collaborations
Stuart collaborates with notable colleagues, including Fady Malik and Stephen B Heitner. Their combined expertise enhances the research and development efforts at Cytokinetics, fostering an environment of innovation and discovery.
Conclusion
Stuart Kupfer's contributions to the treatment of hypertrophic cardiomyopathy exemplify the impact of innovation in medicine. His patent and work at Cytokinetics, Inc. highlight the importance of personalized treatment approaches in improving patient outcomes.